Yüklüyor......
An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?
As patents on many high-selling biological medicines are expiring, non-innovator versions, such as biosimilars, may enter this multi-billion dollar market. This study aims to map patents and patent applications for innovator as well as biosimilar monoclonal antibodies in Europe, and investigates leg...
Kaydedildi:
| Yayımlandı: | MAbs |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7188399/ https://ncbi.nlm.nih.gov/pubmed/32306833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2020.1743517 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|